Riskpilot← Back to searchSign inGet full accessBio Research and development A/S
A/SBankruptCVR 38456229Roholmsvej 10NWholesale of china and glassware and cleaning materials · NACE 4644Est. 20173 employees
Revenue 2021
DKK -795K
-125% vs 2020
EBITDA margin
234.2%
-182% vs 2020
Equity ratio
-77.0%
Financial strength
Net profit 2021
DKK -1,9M
-206% vs 2020
| Revenue | DKK -795K | -125% |
| EBITDA | DKK -1,9M | -182% |
| Net profit | DKK -1,9M | -206% |
| Total assets | DKK 1,1M | -64% |
| Equity | DKK -855K | -162% |
| Employees | 3 | — |
Legal name
Bio Research and development A/S
CVR number
38456229
Legal form
Aktieselskab
NACE code
4644 · Wholesale of china and glassware and cleaning materials
Founded
16. februar 2017
Share capital
DKK 400.000
Employees
3 (FTE)
VAT registered
No
Audit selected
No
Last report
2021-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af en direktør alene.
Address
Roholmsvej 10N
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2017 | 2018 | 2019 | 2020 | 2021 |
|---|---|---|---|---|---|
| Revenue | 85 | 198 | -379 | 3.189 | -795 |
| Staff expenses | -49 | -116 | -137 | -910 | -1.067 |
| EBITDA | 36 | 82 | -516 | 2.280 | -1.862 |
| Depreciation & amort. | -3 | -8 | -8 | -33 | -52 |
| EBIT | 33 | 74 | -525 | 2.246 | -1.914 |
| Net financials | -1 | -16 | 10 | -40 | -32 |
| Profit before tax | 32 | 58 | -514 | 2.206 | -1.946 |
| Tax | 5 | 23 | -3 | 380 | -14 |
| Net profit | 27 | 35 | -511 | 1.826 | -1.933 |
| Item | 2017 | 2018 | 2019 | 2020 | 2021 |
|---|---|---|---|---|---|
| Total assets | 349 | 450 | 253 | 3.095 | 1.110 |
| Equity | 27 | 63 | -448 | 1.378 | -855 |
| Long-term debt | 0 | 0 | 0 | 769 | 0 |
| Short-term debt | 322 | 384 | 702 | 935 | 1.965 |
| Total debt | 322 | 384 | 702 | 1.704 | 1.965 |
EBITDA margin
-186220400.0%
This company
15.8%
Market median
-1178610227% vs market
20172021
Equity ratio
-77.0%
This company
38.2%
Market median
-302% vs market
20172021
Return on equity
-193255500.0%
This company
18.4%
Market median
-1050301730% vs market
20172021
Net profit margin
-193255500.0%
This company
8.1%
Market median
-2385870470% vs market
20172021
Asset turnover
-0.72×
This company
1.12×
Market median
-164% vs market
20172021
Debt / equity
2.30×
This company
0.62×
Market median
-271% vs market
20172021
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via CVR / Virk · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via CVR / Virk · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via CVR / Virk · Period 2017-02-16 – 2017-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Former (3) | ||
| Chairman | 2021 – 2022 | |
| Board of Directors | 2021 – 2022 | |
| Board of Directors | 2021 – 2022 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 100% | 100% | 2018 | |
| Company | 66.67–89.99% | 66.67–89.99% | 2017 | |
| Company | 66.67–89.99% | 66.67–89.99% | 2018 | |
| Company | 25–33.32% | 25–33.32% | 2017 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Bio Research and development A/S also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Birthe Juul Nielsen | Chairman | 0 companies |
| Carina Løndahl Nielsen | Board of Directors | 0 companies |
| Jørgen Anders Nielsen | Board of Directors | 0 companies |